Antagonistes calciques. I. Remplacement du groupe diméthoxy-3, 4 phényléthyle du vérapamil

M Laguerre, C Boyer, A Carpy, E Panconi…

Index: European Journal of Medicinal Chemistry, , vol. 25, # 4 p. 351 - 359

Full Text: HTML

Citation Number: 5

Abstract

... Please enable JavaScript to use all the features on this page. European Journal of Medicinal Chemistry. Volume 25, Issue 4, May 1990, Pages 351–359. ... Full Text via CrossRef. 7; F Gualtieri, E Teodori, C Belluci, E Pesce, G Piacenza; J Med Chem, 28 (1985), pp. ...

Related Articles:

Design, synthesis and evaluation of 9-hydroxy-7H-furo [3, 2-g] chromen-7-one derivatives as new potential vasodilatory agents

[Wang, Cheng; Wang, Tao; Zhou, Nan; Pan, Xiao-Yan; He, Huai-Zhen Journal of Asian Natural Products Research, 2014 , vol. 16, # 3 p. 304 - 311]

Antagonistes calciques. I. Remplacement du groupe diméthoxy-3, 4 phényléthyle du vérapamil

[Laguerre, M.; Boyer, C.; Carpy, A.; Panconi, E.; Cognic, F.; Vaugien, B. European Journal of Medicinal Chemistry, 1990 , vol. 25, # 4 p. 351 - 359]

Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time??of??flight and LTQ??Orbitrap mass spectrometers in drug discovery phase metabolite …

[Rapid Communications in Mass Spectrometry, , vol. 24, # 7 p. 939 - 957]

A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds

[Sawayama, Andrew M.; Chen, Michael M. Y.; Kulanthaivel, Palaniappan; Kuo, Ming-Shang; Hemmerle, Horst; Arnold, Frances H. Chemistry - A European Journal, 2009 , vol. 15, # 43 p. 11723 - 11729]

A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds

[Chemistry - A European Journal, , vol. 15, # 43 p. 11723 - 11729]

More Articles...